Pretreatment PSA levels affects the completion rate of Ra-223 treatment
Abstract The aim of this study was to review our initial experience of using radium 223 (Ra-223) for metastatic castration-resistant prostate cancer (CRPC) and to evaluate whether pretreatment PSA levels correlate with completion of Ra-223 treatment. In addition, we examined change ratios of PSA, AL...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b21b6bec7d8547c9b0bee33a89f12746 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|